Kohle Bei Durchfall Und Nahrungsmittelvergiftung (Charcoal, Activated)

Activated charcoal has a highly porous surface that creates a large adsorption area. When taken orally, it binds to toxins, bacterial metabolites and gases in the gut, forming a complex that cannot be absorbed. This reduces the amount of harmful substances entering the bloodstream and helps alleviate symptoms.

The appropriate dose of Kohle Bei Durchfall Und Nahrungsmittelvergiftung is determined by the prescribing healthcare professional based on the patient’s age, weight, severity of symptoms and the specific toxin involved. Dosage instructions are provided on the prescription label and should be followed exactly.

Safety data for activated charcoal in pregnancy and lactation are limited. It should only be used when the potential benefit outweighs any possible risk to the mother or fetus. Healthcare providers will assess the individual situation before recommending use in pregnant or nursing patients.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Unlike pharmacologic antidiarrheals that slow intestinal motility, activated charcoal works by physically binding toxins and gases. This mechanism makes it useful for toxin‑related diarrhoea and food poisoning, whereas agents such as loperamide act on gut motility. Choice of therapy depends on the underlying cause and clinical judgment.

Store the product at room temperature, preferably below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product integrity.

The product is taken orally, usually as a suspension or powder mixed with water according to the prescriber’s instructions. It should be swallowed promptly after preparation and not be chewed, to allow optimal adsorption in the gastrointestinal tract.

Serious risks include aspiration if administered to an unconscious patient, potential bowel obstruction with prolonged high‑dose use, and rare allergic reactions such as rash or anaphylaxis. Patients should be monitored for these events, especially if they have pre‑existing gastrointestinal disorders.

Activated charcoal should be avoided in patients with a known hypersensitivity to charcoal, those with compromised airway protection who are at risk of aspiration, and individuals with intestinal obstruction or severe constipation unless directed by a physician.